PCP
PDLI

Proficio Capital Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Proficio Capital Partners’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,090
Closed -$15K – 2179
2019
Q1 		$15K Buy
+4,090
New +$13.8K 0.01% 770

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Proficio Capital Partners's PDLI Position: Q2 2019 in Review

Proficio Capital Partners sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 4,090 shares — an estimated $15K sold.

Proficio Capital Partners first reported a position in PDLI in Q1 2019 and held it in 1 quarter. The position peaked at $15K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Proficio Capital Partners reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 4,090 PDL BioPharma, Inc. shares in Q2 2019, an estimated $15K.
  • Proficio Capital Partners first reported a position in PDL BioPharma, Inc. in Q1 2019 and held it in 1 quarter.
  • Proficio Capital Partners's PDL BioPharma, Inc. position peaked at $15K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Proficio Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.